Published September 20, 2018 | Version v1

Remote Control of Neuronal Cell Signaling by Cytoplasmic Magnetic Nanoparticles

  • 1. Ruhr-Universität Bochum, Faculty of Chemistry and Biochemistry, Department of Biochemistry II – Molecular Neurobiochemistry, 44801 Bochum, Germany
  • 2. Sorbonne Université, CNRS, Physico-chimie des Électrolytes et Nanosystèmes Interfaciaux, PHENIX, F-75005 Paris, France

Description

Neurodegenerative disorders are a major public health issue affecting the worldwide aging population. Especially, Parkinson's disease (PD) caused by loss and dysfunction of dopaminergic neurons is not curable by pharmacological treatment.
To this date, progressing PD can be retarded mainly by deep brain stimulation (DBS) or antiparkinson medication like levodopa (L-DOPA). In efforts to treat Morbus Parkinson, cell replacement strategies are considered very promising.
However, controlling the cell behavior after transplantation, in particular the directed fibre outgrowth for functional integration in the neuronal network will be a fundamental challenge.

Files

Poster Marburg v2.pdf

Files (5.9 MB)

Name Size Download all
md5:b24c5e4c1af9282115ffbe9437ce9429
5.9 MB Preview Download

Additional details

Funding

European Commission
MAGNEURON - Hijacking cell signalling pathways with magnetic nanoactuators for remote-controlled stem cell therapies of neurodegenerative disorders 686841